Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...

NICE, France — Treating patients with thrombolysis should not be based purely on time, and a stronger predictor of who will benefit most is the amount of dead tissue in the brain as visible on ...

About 87 percent of all strokes are ischemic, meaning they’re caused by a blood clot in the brain. For more than 20 years, the standard of care has been a drug called TPA. But now, some doctors are ...

A study may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA, the 'clot busting' drug that has greatly reduced stroke-related disability ...

Emergency room physicians can deliver clot-busting treatments to a wider range of stroke patients than previously thought, European researchers report in the Sept. 25 New England Journal of Medicine.

The first multicenter study to look at treatments for post-thrombolysis symptomatic intracerebral hemorrhage (ICH) has not shown any significant benefit of using any therapy (mainly cryoprecipitate) ...

Some patients with acute ischemic stroke do not receive treatment with intravenous tissue plasminogen activator (tPA) because their symptoms are mild or they show improvement; however, lack of ...

BOSTON (CBS) - We first told you about the drug tPA (tissue plasminogen activator) last week. Doctors at Beth Israel Deaconess Medical Center are using tPA off-label on critically ill COVID-19 ...

When Houston Texans head coach Gary Kubiak was sent to the emergency room in the middle of Sunday night's game, many viewers wondered about the 52-year-old's health after watching the circumstances ...

A new study published online in the Journal of Trauma and Acute Care Surgery in March 2020 reports that the anticoagulation drug tPA could be a potential aid in managing respiratory failure in ...

A study led by Massachusetts General Hospital (MGH) investigators may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA (tissue ...